This article was originally published in The Tan Sheet
President & CEO A.G. Lafley will add chairman to his title effective July 1; he succeeds John Pepper, who will retire after 38 years with the consumer products firm. Lafley will assume overall responsibility for "business performance, direction and operations," P&G says April 10. Global Beauty Care & Global Health Care President Bruce Byrnes and Global Market Development & Business Operations President Kerry Clark named vice chairmen, directors...
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
Alvogen believes it is the first company to file for a generic pazopanib rival to Novartis’ Votrient oncology brand in Europe.